全体要約
がんゲノム検査市場は、2022年の売上から2029年までの予測を地域別および市場セクター別に分析しています。2022年から2029年にかけて、アメリカ、中国、ヨーロッパの市場はそれぞれ成長が見込まれています。主要企業にはMyriad Genetics、Centogene AG、Color Genomicsなどがあり、2022年には上位2社が市場の大部分を占めています。
このレポートは、がんゲノム検査の製品タイプやアプリケーション、地域別の市場シェアを詳細に示しています。市場は、乳がん、肺がん、血液がん、肝臓がん、胃がんなどのタイプに分かれ、病院、診療所、診断ラボ、研究機関などで利用されています。
関連する質問
Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience, Bio-Rad Laboratories, Illumina, Inc., Agilent Technologies, Thermo Fisher Scientific
製品セグメンテーションのトレンド, 主要企業の戦略分析, 地理的フットプリントの評価
概要
このインサイトレポートは、グローバルな癌ゲノム検査の状況について包括的な分析を提供し、製品セグメンテーション、企業の形成、収益、市場シェア、最新の開発、およびM&A活動に関連する重要なトレンドを強調しています。また、このレポートは、癌ゲノム検査のポートフォリオと能力、市場参入戦略、市場ポジション、地理的プレゼンスに焦点を当て、グローバルな癌ゲノム検査市場が加速する中で、これらの企業の独自の位置をより良く理解するために、主要なグローバル企業の戦略を分析しています。
このインサイトレポートは、がんゲノム検査の世界的な展望を形作る主要な市場トレンド、ドライバー、および要因を評価し、種類、用途、地理、そして市場規模による予測を分解して、新たな機会のポケットを強調します。数百のボトムアップの定性および定量的な市場データに基づいた透明な方法論を用いたこの研究予測は、現在の状況と未来の軌道に関する非常に微細な見解を提供します。
世界の癌ゲノム検査市場の規模は、2022年のXX米ドルから2029年のXX米ドルまで成長することが予測されています。2023年から2029年にかけてXX%のCAGRで成長することが期待されています。
米国のがんゲノム検査市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%の年平均成長率（CAGR）を記録する見込みです。
中国のがんゲノム検査市場は、2022年のアメリカドル百万から2029年にはアメリカドル百万に増加すると推定されており、2023年から2029年の間でXX%のCAGRが見込まれています。
ヨーロッパにおけるがんゲノム検査市場は、2022年のXX米ドルから2029年までにXX米ドルに増加すると推定されており、2023年から2029年の間にXX%のCAGRです。
世界の主要な癌ゲノム検査のプレイヤーには、マイリアド・ジェネティクス、センテゲン・AG、カラー・ゲノミクス、クエスト・ダイアグノスティックス、23andMe社、ジーン・バイ・ジーン社、ラボコープ、ポジティブ・バイオサイエンス、バイオラッド・ラボラトリーズなどが含まれます。収益の観点から、2022年には世界の二大企業がほぼXX%のシェアを占めていました。
この報告書は、癌ゲノム検査市場の製品タイプ、アプリケーション、主要プレーヤー、主要地域および国ごとの包括的な概要、市場シェア、および成長機会を示しています。
市場セグメンテーション：
タイプ別セグメンテーション
乳がんゲノム検査
肺癌ゲノム検査
血液癌のゲノム検査
肝癌のゲノム検査
胃癌のゲノム検査
その他
用途別セグメンテーション
病院
クリニック
診断検査室
学術および研究機関
その他
この報告書は市場を地域別にも分割しています：
アメリカ大陸
アメリカ合衆国
カナダ
メキシコ
ブラジル
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東およびアフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、主要な専門家からの情報収集と企業のカバレッジ、製品ポートフォリオ、市場浸透度を分析した結果に基づいて選定されました。
マイリアド・ジェネティクス
センコジーン株式会社
カラーゲノミクス
クエスト・ダイアグノスティクス
23andMe社
Gene By Gene株式会社
ラボコープ
ポジティブバイオサイエンス
バイオラッドラボラトリーズ
イルミナ社
アジレント・テクノロジーズ
サーモフィッシャーサイエンティフィック
※以下の目次にて、具体的なレポートの構成をご覧頂けます。ご購入、無料サンプルご請求、その他お問い合わせは、ページ上のボタンよりお進みください。
目次
1 調査範囲
1.1 市場イントロダクション
1.2 対象年
1.3 調査目的
1.4 市場調査手法
1.5 調査プロセスとデータソース
1.6 経済指標
1.7 通貨
1.8 市場予測における留意事項
2 エグゼクティブサマリー
2.1 世界市場概要
2.1.1 グローバルのがんゲノム検査市場規模、（2018年～2029年）
2.1.2 がんゲノム検査市場規模、CAGR（地域別）（2018年 vs 2022年 vs 2029年）
2.2 がんゲノム検査セグメント、タイプ別
2.2.1 乳がんゲノム検査
2.2.2 肺がんゲノム検査
2.2.3 血液がんゲノム検査
2.2.4 肝がんゲノム検査
2.2.5 胃がんゲノム検査
2.2.6 その他
2.3 がんゲノム検査市場規模：タイプ別
2.3.1 がんゲノム検査市場規模、CAGR（タイプ別）（2018年 vs 2022年 vs 2029年）
2.3.2 グローバルのがんゲノム検査市場規模、市場シェア（タイプ別）（2018年～2023年）
2.4 がんゲノム検査セグメント、用途別
2.4.1 病院
2.4.2 クリニック
2.4.3 検査室
2.4.4 アカデミック・研究機関
2.4.5 その他
2.5 がんゲノム検査市場規模：用途別
2.5.1 がんゲノム検査市場規模、CAGR（用途別）（2018年 vs 2022年 vs 2029年）
2.5.2 グローバルのがんゲノム検査市場規模、市場シェア（用途別）（2018年～2023年）
3 がんゲノム検査市場規模：プレイヤー別
3.1 がんゲノム検査市場規模、市場シェア（プレイヤー別）
3.1.1 グローバルにおけるがんゲノム検査市場の収益規模、プレイヤー別（2018年～2023年）
3.1.2 グローバルにおけるがんゲノム検査市場の収益シェア、プレイヤー別（2018年～2023年）
3.2 グローバルのがんゲノム検査市場キープレイヤー拠点および提供製品
3.3 市場集中度分析
3.3.1 競合情勢分析
3.3.2 集中度レシオ（CR3、CR5、CR10）（2021年～2023年）
3.4 新製品・潜在的参入
3.5 M&A、拡大
4 がんゲノム検査、地域別
4.1 がんゲノム検査市場規模（地域別）（2018年～2023年）
4.2 アメリカズにおけるがんゲノム検査市場規模成長（2018年〜2023年）
4.3 APACにおけるがんゲノム検査市場規模成長（2018年〜2023年）
4.4 ヨーロッパにおけるがんゲノム検査市場規模成長（2018年〜2023年）
4.5 中東・アフリカにおけるがんゲノム検査市場規模成長（2018年〜2023年）
5 アメリカズ
5.1 アメリカズにおけるがんゲノム検査市場規模、国別（2018年〜2023年）
5.2 アメリカズにおけるがんゲノム検査市場規模、タイプ別（2018年〜2023年）
5.3 アメリカズにおけるがんゲノム検査市場規模、用途別（2018年〜2023年）
5.4 米国
5.5 カナダ
5.6 メキシコ
5.7 ブラジル
6 APAC
6.1 APACにおけるがんゲノム検査市場規模、地域別（2018年〜2023年）
6.2 APACにおけるがんゲノム検査市場規模、タイプ別（2018年〜2023年）
6.3 APACにおけるがんゲノム検査市場規模、用途別（2018年〜2023年）
6.4 中国
6.5 日本
6.6 韓国
6.7 東南アジア
6.8 インド
6.9 オーストラリア
7 ヨーロッパ
7.1 ヨーロッパのがんゲノム検査 国別（2018年～2023年）
7.2 ヨーロッパにおけるがんゲノム検査市場規模、タイプ別（2018年〜2023年）
7.3 ヨーロッパにおけるがんゲノム検査市場規模、用途別（2018年〜2023年）
7.4 ドイツ
7.5 フランス
7.6 英国
7.7 イタリア
7.8 ロシア
8 中東・アフリカ
8.1 中東・アフリカのがんゲノム検査 地域別（2018年～2023年）
8.2 中東・アフリカにおけるがんゲノム検査市場規模、タイプ別（2018年〜2023年）
8.3 中東・アフリカにおけるがんゲノム検査市場規模、用途別（2018年〜2023年）
8.4 エジプト
8.5 南アフリカ
8.6 イスラエル
8.7 トルコ
8.8 GCC地域
9 市場ドライバー・課題・トレンド
9.1 市場ドライバー・成長機会
9.2 市場課題・リスク
9.3 業界トレンド
10 グローバルのがんゲノム検査市場、市場予測
10.1 グローバルのがんゲノム検査、市場予測（地域別）（2024年～2029年）
10.1.1 グローバルのがんゲノム検査、市場予測（地域別）（2024年～2029年）
10.1.2 アメリカズのがんゲノム検査、市場予測
10.1.3 APACのがんゲノム検査、市場予測
10.1.4 ヨーロッパのがんゲノム検査、市場予測
10.1.5 中東・アフリカのがんゲノム検査、市場予測
10.2 アメリカズのがんゲノム検査、市場予測（国別）（2024年～2029年）
10.3 APACのがんゲノム検査、市場予測（地域別）（2024年～2029年）
10.4 ヨーロッパのがんゲノム検査、市場予測（国別）（2024年～2029年）
10.5 中東・アフリカのがんゲノム検査、市場予測（地域別）（2024年～2029年）
10.6 グローバルのがんゲノム検査、市場予測（タイプ別）（2024年～2029年）
10.7 グローバルのがんゲノム検査、市場予測（用途別）（2024年～2029年）
11 キープレイヤー分析
11.1 Myriad Genetics
11.1.1 Myriad Genetics：企業情報
11.1.2 Myriad Genetics：がんゲノム検査分野の提供製品
11.1.3 Myriad Genetics：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.1.4 Myriad Genetics：主要事業概要
11.1.5 Myriad Genetics：直近の展開
11.2 Centogene AG
11.2.1 Centogene AG：企業情報
11.2.2 Centogene AG：がんゲノム検査分野の提供製品
11.2.3 Centogene AG：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.2.4 Centogene AG：主要事業概要
11.2.5 Centogene AG：直近の展開
11.3 Color Genomics
11.3.1 Color Genomics：企業情報
11.3.2 Color Genomics：がんゲノム検査分野の提供製品
11.3.3 Color Genomics：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.3.4 Color Genomics：主要事業概要
11.3.5 Color Genomics：直近の展開
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics：企業情報
11.4.2 Quest Diagnostics：がんゲノム検査分野の提供製品
11.4.3 Quest Diagnostics：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.4.4 Quest Diagnostics：主要事業概要
11.4.5 Quest Diagnostics：直近の展開
11.5 23andMe Inc
11.6 Gene By Gene Ltd
11.7 LabCorp
11.7.1 LabCorp：企業情報
11.7.2 LabCorp：がんゲノム検査分野の提供製品
11.7.3 LabCorp：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.7.4 LabCorp：主要事業概要
11.7.5 LabCorp：直近の展開
11.8 Positive Bioscience
11.8.1 Positive Bioscience：企業情報
11.8.2 Positive Bioscience：がんゲノム検査分野の提供製品
11.8.3 Positive Bioscience：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.8.4 Positive Bioscience：主要事業概要
11.8.5 Positive Bioscience：直近の展開
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories：企業情報
11.9.2 Bio-Rad Laboratories：がんゲノム検査分野の提供製品
11.9.3 Bio-Rad Laboratories：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.9.4 Bio-Rad Laboratories：主要事業概要
11.9.5 Bio-Rad Laboratories：直近の展開
11.10 Illumina, Inc
11.11 Agilent Technologies
11.11.1 Agilent Technologies：企業情報
11.11.2 Agilent Technologies：がんゲノム検査分野の提供製品
11.11.3 Agilent Technologies：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.11.4 Agilent Technologies：主要事業概要
11.11.5 Agilent Technologies：直近の展開
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific：企業情報
11.12.2 Thermo Fisher Scientific：がんゲノム検査分野の提供製品
11.12.3 Thermo Fisher Scientific：がんゲノム検査収益・グロスマージンおよび市場シェア（2018年～2023年）
11.12.4 Thermo Fisher Scientific：主要事業概要
11.12.5 Thermo Fisher Scientific：直近の展開
12 調査の結果・結論
※英文のレポートについての日本語表記のタイトルや紹介文などは、すべて生成AIや自動翻訳ソフトを使用して提供しております。それらはお客様の便宜のために提供するものであり、当社はその内容について責任を負いかねますので、何卒ご了承ください。適宜英語の原文をご参照ください。
“All Japanese titles, abstracts, and other descriptions of English-language reports were created using generative AI and/or machine translation. These are provided for your convenience only and may contain errors and inaccuracies. Please be sure to refer to the original English-language text. We disclaim all liability in relation to your reliance on such AI-generated and/or machine-translated content.”
Description
This Insight Report provides a comprehensive analysis of the global Cancer Genomic Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cancer Genomic Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cancer Genomic Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cancer Genomic Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cancer Genomic Testing.
The global Cancer Genomic Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cancer Genomic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cancer Genomic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cancer Genomic Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cancer Genomic Testing players cover Myriad Genetics, Centogene AG, Color Genomics, Quest Diagnostics, 23andMe Inc., Gene By Gene Ltd., LabCorp, Positive Bioscience and Bio-Rad Laboratories, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Cancer Genomic Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Breast Cancer Genomic Testing
Lung Cancer Genomic Testing
Blood Cancer Genomic Testing
Liver Cancer Genomic Testing
Stomach Cancer Genomic Testing
Others
Segmentation by application
Hospitals
Clinics
Diagnostic Laboratories
Academic and Research Institutes
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Myriad Genetics
Centogene AG
Color Genomics
Quest Diagnostics
23andMe Inc.
Gene By Gene Ltd.
LabCorp
Positive Bioscience
Bio-Rad Laboratories
Illumina, Inc.
Agilent Technologies
Thermo Fisher Scientific
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cancer Genomic Testing Market Size 2018-2029
2.1.2 Cancer Genomic Testing Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cancer Genomic Testing Segment by Type
2.2.1 Breast Cancer Genomic Testing
2.2.2 Lung Cancer Genomic Testing
2.2.3 Blood Cancer Genomic Testing
2.2.4 Liver Cancer Genomic Testing
2.2.5 Stomach Cancer Genomic Testing
2.2.6 Others
2.3 Cancer Genomic Testing Market Size by Type
2.3.1 Cancer Genomic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cancer Genomic Testing Market Size Market Share by Type (2018-2023)
2.4 Cancer Genomic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Diagnostic Laboratories
2.4.4 Academic and Research Institutes
2.4.5 Others
2.5 Cancer Genomic Testing Market Size by Application
2.5.1 Cancer Genomic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cancer Genomic Testing Market Size Market Share by Application (2018-2023)
3 Cancer Genomic Testing Market Size by Player
3.1 Cancer Genomic Testing Market Size Market Share by Players
3.1.1 Global Cancer Genomic Testing Revenue by Players (2018-2023)
3.1.2 Global Cancer Genomic Testing Revenue Market Share by Players (2018-2023)
3.2 Global Cancer Genomic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Cancer Genomic Testing by Regions
4.1 Cancer Genomic Testing Market Size by Regions (2018-2023)
4.2 Americas Cancer Genomic Testing Market Size Growth (2018-2023)
4.3 APAC Cancer Genomic Testing Market Size Growth (2018-2023)
4.4 Europe Cancer Genomic Testing Market Size Growth (2018-2023)
4.5 Middle East & Africa Cancer Genomic Testing Market Size Growth (2018-2023)
5 Americas
5.1 Americas Cancer Genomic Testing Market Size by Country (2018-2023)
5.2 Americas Cancer Genomic Testing Market Size by Type (2018-2023)
5.3 Americas Cancer Genomic Testing Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cancer Genomic Testing Market Size by Region (2018-2023)
6.2 APAC Cancer Genomic Testing Market Size by Type (2018-2023)
6.3 APAC Cancer Genomic Testing Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Cancer Genomic Testing by Country (2018-2023)
7.2 Europe Cancer Genomic Testing Market Size by Type (2018-2023)
7.3 Europe Cancer Genomic Testing Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Cancer Genomic Testing by Region (2018-2023)
8.2 Middle East & Africa Cancer Genomic Testing Market Size by Type (2018-2023)
8.3 Middle East & Africa Cancer Genomic Testing Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Cancer Genomic Testing Market Forecast
10.1 Global Cancer Genomic Testing Forecast by Regions (2024-2029)
10.1.1 Global Cancer Genomic Testing Forecast by Regions (2024-2029)
10.1.2 Americas Cancer Genomic Testing Forecast
10.1.3 APAC Cancer Genomic Testing Forecast
10.1.4 Europe Cancer Genomic Testing Forecast
10.1.5 Middle East & Africa Cancer Genomic Testing Forecast
10.2 Americas Cancer Genomic Testing Forecast by Country (2024-2029)
10.2.1 United States Cancer Genomic Testing Market Forecast
10.2.2 Canada Cancer Genomic Testing Market Forecast
10.2.3 Mexico Cancer Genomic Testing Market Forecast
10.2.4 Brazil Cancer Genomic Testing Market Forecast
10.3 APAC Cancer Genomic Testing Forecast by Region (2024-2029)
10.3.1 China Cancer Genomic Testing Market Forecast
10.3.2 Japan Cancer Genomic Testing Market Forecast
10.3.3 Korea Cancer Genomic Testing Market Forecast
10.3.4 Southeast Asia Cancer Genomic Testing Market Forecast
10.3.5 India Cancer Genomic Testing Market Forecast
10.3.6 Australia Cancer Genomic Testing Market Forecast
10.4 Europe Cancer Genomic Testing Forecast by Country (2024-2029)
10.4.1 Germany Cancer Genomic Testing Market Forecast
10.4.2 France Cancer Genomic Testing Market Forecast
10.4.3 UK Cancer Genomic Testing Market Forecast
10.4.4 Italy Cancer Genomic Testing Market Forecast
10.4.5 Russia Cancer Genomic Testing Market Forecast
10.5 Middle East & Africa Cancer Genomic Testing Forecast by Region (2024-2029)
10.5.1 Egypt Cancer Genomic Testing Market Forecast
10.5.2 South Africa Cancer Genomic Testing Market Forecast
10.5.3 Israel Cancer Genomic Testing Market Forecast
10.5.4 Turkey Cancer Genomic Testing Market Forecast
10.5.5 GCC Countries Cancer Genomic Testing Market Forecast
10.6 Global Cancer Genomic Testing Forecast by Type (2024-2029)
10.7 Global Cancer Genomic Testing Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Myriad Genetics
11.1.1 Myriad Genetics Company Information
11.1.2 Myriad Genetics Cancer Genomic Testing Product Offered
11.1.3 Myriad Genetics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Myriad Genetics Main Business Overview
11.1.5 Myriad Genetics Latest Developments
11.2 Centogene AG
11.2.1 Centogene AG Company Information
11.2.2 Centogene AG Cancer Genomic Testing Product Offered
11.2.3 Centogene AG Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Centogene AG Main Business Overview
11.2.5 Centogene AG Latest Developments
11.3 Color Genomics
11.3.1 Color Genomics Company Information
11.3.2 Color Genomics Cancer Genomic Testing Product Offered
11.3.3 Color Genomics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Color Genomics Main Business Overview
11.3.5 Color Genomics Latest Developments
11.4 Quest Diagnostics
11.4.1 Quest Diagnostics Company Information
11.4.2 Quest Diagnostics Cancer Genomic Testing Product Offered
11.4.3 Quest Diagnostics Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Quest Diagnostics Main Business Overview
11.4.5 Quest Diagnostics Latest Developments
11.5 23andMe Inc.
11.5.1 23andMe Inc. Company Information
11.5.2 23andMe Inc. Cancer Genomic Testing Product Offered
11.5.3 23andMe Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 23andMe Inc. Main Business Overview
11.5.5 23andMe Inc. Latest Developments
11.6 Gene By Gene Ltd.
11.6.1 Gene By Gene Ltd. Company Information
11.6.2 Gene By Gene Ltd. Cancer Genomic Testing Product Offered
11.6.3 Gene By Gene Ltd. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Gene By Gene Ltd. Main Business Overview
11.6.5 Gene By Gene Ltd. Latest Developments
11.7 LabCorp
11.7.1 LabCorp Company Information
11.7.2 LabCorp Cancer Genomic Testing Product Offered
11.7.3 LabCorp Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 LabCorp Main Business Overview
11.7.5 LabCorp Latest Developments
11.8 Positive Bioscience
11.8.1 Positive Bioscience Company Information
11.8.2 Positive Bioscience Cancer Genomic Testing Product Offered
11.8.3 Positive Bioscience Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Positive Bioscience Main Business Overview
11.8.5 Positive Bioscience Latest Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Information
11.9.2 Bio-Rad Laboratories Cancer Genomic Testing Product Offered
11.9.3 Bio-Rad Laboratories Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Bio-Rad Laboratories Main Business Overview
11.9.5 Bio-Rad Laboratories Latest Developments
11.10 Illumina, Inc.
11.10.1 Illumina, Inc. Company Information
11.10.2 Illumina, Inc. Cancer Genomic Testing Product Offered
11.10.3 Illumina, Inc. Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Illumina, Inc. Main Business Overview
11.10.5 Illumina, Inc. Latest Developments
11.11 Agilent Technologies
11.11.1 Agilent Technologies Company Information
11.11.2 Agilent Technologies Cancer Genomic Testing Product Offered
11.11.3 Agilent Technologies Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Agilent Technologies Main Business Overview
11.11.5 Agilent Technologies Latest Developments
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Information
11.12.2 Thermo Fisher Scientific Cancer Genomic Testing Product Offered
11.12.3 Thermo Fisher Scientific Cancer Genomic Testing Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Thermo Fisher Scientific Main Business Overview
11.12.5 Thermo Fisher Scientific Latest Developments
12 Research Findings and Conclusion
List of Tables Table 1. Cancer Genomic Testing Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Breast Cancer Genomic Testing Table 3. Major Players of Lung Cancer Genomic Testing Table 4. Major Players of Blood Cancer Genomic Testing Table 5. Major Players of Liver Cancer Genomic Testing Table 6. Major Players of Stomach Cancer Genomic Testing Table 7. Major Players of Others Table 8. Cancer Genomic Testing Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 9. Global Cancer Genomic Testing Market Size by Type (2018-2023) & ($ Millions) Table 10. Global Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Table 11. Cancer Genomic Testing Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 12. Global Cancer Genomic Testing Market Size by Application (2018-2023) & ($ Millions) Table 13. Global Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Table 14. Global Cancer Genomic Testing Revenue by Players (2018-2023) & ($ Millions) Table 15. Global Cancer Genomic Testing Revenue Market Share by Player (2018-2023) Table 16. Cancer Genomic Testing Key Players Head office and Products Offered Table 17. Cancer Genomic Testing Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 18. New Products and Potential Entrants Table 19. Mergers & Acquisitions, Expansion Table 20. Global Cancer Genomic Testing Market Size by Regions 2018-2023 & ($ Millions) Table 21. Global Cancer Genomic Testing Market Size Market Share by Regions (2018-2023) Table 22. Global Cancer Genomic Testing Revenue by Country/Region (2018-2023) & ($ millions) Table 23. Global Cancer Genomic Testing Revenue Market Share by Country/Region (2018-2023) Table 24. Americas Cancer Genomic Testing Market Size by Country (2018-2023) & ($ Millions) Table 25. Americas Cancer Genomic Testing Market Size Market Share by Country (2018-2023) Table 26. Americas Cancer Genomic Testing Market Size by Type (2018-2023) & ($ Millions) Table 27. Americas Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Table 28. Americas Cancer Genomic Testing Market Size by Application (2018-2023) & ($ Millions) Table 29. Americas Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Table 30. APAC Cancer Genomic Testing Market Size by Region (2018-2023) & ($ Millions) Table 31. APAC Cancer Genomic Testing Market Size Market Share by Region (2018-2023) Table 32. APAC Cancer Genomic Testing Market Size by Type (2018-2023) & ($ Millions) Table 33. APAC Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Table 34. APAC Cancer Genomic Testing Market Size by Application (2018-2023) & ($ Millions) Table 35. APAC Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Table 36. Europe Cancer Genomic Testing Market Size by Country (2018-2023) & ($ Millions) Table 37. Europe Cancer Genomic Testing Market Size Market Share by Country (2018-2023) Table 38. Europe Cancer Genomic Testing Market Size by Type (2018-2023) & ($ Millions) Table 39. Europe Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Table 40. Europe Cancer Genomic Testing Market Size by Application (2018-2023) & ($ Millions) Table 41. Europe Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Table 42. Middle East & Africa Cancer Genomic Testing Market Size by Region (2018-2023) & ($ Millions) Table 43. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Region (2018-2023) Table 44. Middle East & Africa Cancer Genomic Testing Market Size by Type (2018-2023) & ($ Millions) Table 45. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Table 46. Middle East & Africa Cancer Genomic Testing Market Size by Application (2018-2023) & ($ Millions) Table 47. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Table 48. Key Market Drivers & Growth Opportunities of Cancer Genomic Testing Table 49. Key Market Challenges & Risks of Cancer Genomic Testing Table 50. Key Industry Trends of Cancer Genomic Testing Table 51. Global Cancer Genomic Testing Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 52. Global Cancer Genomic Testing Market Size Market Share Forecast by Regions (2024-2029) Table 53. Global Cancer Genomic Testing Market Size Forecast by Type (2024-2029) & ($ Millions) Table 54. Global Cancer Genomic Testing Market Size Forecast by Application (2024-2029) & ($ Millions) Table 55. Myriad Genetics Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 56. Myriad Genetics Cancer Genomic Testing Product Offered Table 57. Myriad Genetics Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 58. Myriad Genetics Main Business Table 59. Myriad Genetics Latest Developments Table 60. Centogene AG Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 61. Centogene AG Cancer Genomic Testing Product Offered Table 62. Centogene AG Main Business Table 63. Centogene AG Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 64. Centogene AG Latest Developments Table 65. Color Genomics Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 66. Color Genomics Cancer Genomic Testing Product Offered Table 67. Color Genomics Main Business Table 68. Color Genomics Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 69. Color Genomics Latest Developments Table 70. Quest Diagnostics Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 71. Quest Diagnostics Cancer Genomic Testing Product Offered Table 72. Quest Diagnostics Main Business Table 73. Quest Diagnostics Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 74. Quest Diagnostics Latest Developments Table 75. 23andMe Inc. Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 76. 23andMe Inc. Cancer Genomic Testing Product Offered Table 77. 23andMe Inc. Main Business Table 78. 23andMe Inc. Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 79. 23andMe Inc. Latest Developments Table 80. Gene By Gene Ltd. Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 81. Gene By Gene Ltd. Cancer Genomic Testing Product Offered Table 82. Gene By Gene Ltd. Main Business Table 83. Gene By Gene Ltd. Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 84. Gene By Gene Ltd. Latest Developments Table 85. LabCorp Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 86. LabCorp Cancer Genomic Testing Product Offered Table 87. LabCorp Main Business Table 88. LabCorp Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 89. LabCorp Latest Developments Table 90. Positive Bioscience Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 91. Positive Bioscience Cancer Genomic Testing Product Offered Table 92. Positive Bioscience Main Business Table 93. Positive Bioscience Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 94. Positive Bioscience Latest Developments Table 95. Bio-Rad Laboratories Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 96. Bio-Rad Laboratories Cancer Genomic Testing Product Offered Table 97. Bio-Rad Laboratories Main Business Table 98. Bio-Rad Laboratories Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 99. Bio-Rad Laboratories Latest Developments Table 100. Illumina, Inc. Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 101. Illumina, Inc. Cancer Genomic Testing Product Offered Table 102. Illumina, Inc. Main Business Table 103. Illumina, Inc. Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 104. Illumina, Inc. Latest Developments Table 105. Agilent Technologies Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 106. Agilent Technologies Cancer Genomic Testing Product Offered Table 107. Agilent Technologies Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 108. Agilent Technologies Main Business Table 109. Agilent Technologies Latest Developments Table 110. Thermo Fisher Scientific Details, Company Type, Cancer Genomic Testing Area Served and Its Competitors Table 111. Thermo Fisher Scientific Cancer Genomic Testing Product Offered Table 112. Thermo Fisher Scientific Main Business Table 113. Thermo Fisher Scientific Cancer Genomic Testing Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 114. Thermo Fisher Scientific Latest Developments List of Figures Figure 1. Cancer Genomic Testing Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Cancer Genomic Testing Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Cancer Genomic Testing Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Cancer Genomic Testing Sales Market Share by Country/Region (2022) Figure 8. Cancer Genomic Testing Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Cancer Genomic Testing Market Size Market Share by Type in 2022 Figure 10. Cancer Genomic Testing in Hospitals Figure 11. Global Cancer Genomic Testing Market: Hospitals (2018-2023) & ($ Millions) Figure 12. Cancer Genomic Testing in Clinics Figure 13. Global Cancer Genomic Testing Market: Clinics (2018-2023) & ($ Millions) Figure 14. Cancer Genomic Testing in Diagnostic Laboratories Figure 15. Global Cancer Genomic Testing Market: Diagnostic Laboratories (2018-2023) & ($ Millions) Figure 16. Cancer Genomic Testing in Academic and Research Institutes Figure 17. Global Cancer Genomic Testing Market: Academic and Research Institutes (2018-2023) & ($ Millions) Figure 18. Cancer Genomic Testing in Others Figure 19. Global Cancer Genomic Testing Market: Others (2018-2023) & ($ Millions) Figure 20. Global Cancer Genomic Testing Market Size Market Share by Application in 2022 Figure 21. Global Cancer Genomic Testing Revenue Market Share by Player in 2022 Figure 22. Global Cancer Genomic Testing Market Size Market Share by Regions (2018-2023) Figure 23. Americas Cancer Genomic Testing Market Size 2018-2023 ($ Millions) Figure 24. APAC Cancer Genomic Testing Market Size 2018-2023 ($ Millions) Figure 25. Europe Cancer Genomic Testing Market Size 2018-2023 ($ Millions) Figure 26. Middle East & Africa Cancer Genomic Testing Market Size 2018-2023 ($ Millions) Figure 27. Americas Cancer Genomic Testing Value Market Share by Country in 2022 Figure 28. United States Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 29. Canada Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 30. Mexico Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 31. Brazil Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 32. APAC Cancer Genomic Testing Market Size Market Share by Region in 2022 Figure 33. APAC Cancer Genomic Testing Market Size Market Share by Type in 2022 Figure 34. APAC Cancer Genomic Testing Market Size Market Share by Application in 2022 Figure 35. China Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 36. Japan Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 37. Korea Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 38. Southeast Asia Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 39. India Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 40. Australia Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 41. Europe Cancer Genomic Testing Market Size Market Share by Country in 2022 Figure 42. Europe Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Figure 43. Europe Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Figure 44. Germany Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 45. France Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 46. UK Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 47. Italy Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 48. Russia Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 49. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Region (2018-2023) Figure 50. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Type (2018-2023) Figure 51. Middle East & Africa Cancer Genomic Testing Market Size Market Share by Application (2018-2023) Figure 52. Egypt Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 53. South Africa Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 54. Israel Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 55. Turkey Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 56. GCC Country Cancer Genomic Testing Market Size Growth 2018-2023 ($ Millions) Figure 57. Americas Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 58. APAC Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 59. Europe Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 60. Middle East & Africa Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 61. United States Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 62. Canada Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 63. Mexico Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 64. Brazil Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 65. China Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 66. Japan Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 67. Korea Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 68. Southeast Asia Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 69. India Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 70. Australia Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 71. Germany Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 72. France Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 73. UK Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 74. Italy Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 75. Russia Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 76. Spain Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 77. Egypt Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 78. South Africa Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 79. Israel Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 80. Turkey Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 81. GCC Countries Cancer Genomic Testing Market Size 2024-2029 ($ Millions) Figure 82. Global Cancer Genomic Testing Market Size Market Share Forecast by Type (2024-2029) Figure 83. Global Cancer Genomic Testing Market Size Market Share Forecast by Application (2024-2029)
